HUTCHMED Announces Vesting of LTIP Awards
Why we think this is neutral
This RNS is a routine regulatory announcement regarding the vesting of non-performance based LTIP awards to an executive. It does not contain any material financial information or impact to the business.
Key Points
- Vesting of 19,913 ordinary shares under LTIP awards granted to Dr. Weiguo Su on March 13, 2024
Summary
The biopharmaceutical company announces the vesting of LTIP awards to its Executive Director and Chief Executive Officer.
HUTCHMED (China) Limited has announced the vesting of non-performance based awards granted under the company's Long Term Incentive Plan (LTIP) to Dr. Weiguo Su, the Executive Director, Chief Executive Officer and Chief Scientific Officer. No other financial details were provided in the RNS.
DIRECTOR DEALINGS